rs111033580
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_000732.6(CD3D):c.202C>T(p.Arg68Ter) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000533 in 1,613,980 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_000732.6 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CD3D | NM_000732.6 | c.202C>T | p.Arg68Ter | stop_gained | 2/5 | ENST00000300692.9 | NP_000723.1 | |
CD3D | NM_001040651.2 | c.202C>T | p.Arg68Ter | stop_gained | 2/4 | NP_001035741.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CD3D | ENST00000300692.9 | c.202C>T | p.Arg68Ter | stop_gained | 2/5 | 1 | NM_000732.6 | ENSP00000300692 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152026Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000199 AC: 5AN: 251488Hom.: 0 AF XY: 0.00000736 AC XY: 1AN XY: 135920
GnomAD4 exome AF: 0.0000554 AC: 81AN: 1461836Hom.: 0 Cov.: 32 AF XY: 0.0000564 AC XY: 41AN XY: 727218
GnomAD4 genome AF: 0.0000329 AC: 5AN: 152144Hom.: 0 Cov.: 31 AF XY: 0.0000403 AC XY: 3AN XY: 74372
ClinVar
Submissions by phenotype
Immunodeficiency 19 Pathogenic:4
Pathogenic, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Feb 18, 2022 | - - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Nov 01, 2011 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 16, 2024 | This sequence change creates a premature translational stop signal (p.Arg68*) in the CD3D gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CD3D are known to be pathogenic (PMID: 14602880, 15546002). This variant is present in population databases (rs111033580, gnomAD 0.004%). This premature translational stop signal has been observed in individuals with severe combined immunodeficiency (SCID) (PMID: 14602880, 15546002, 21883749, 22039266, 27807805). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 12747). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. - |
Pathogenic, criteria provided, single submitter | clinical testing | Institute of Human Genetics, University of Leipzig Medical Center | Jun 14, 2023 | Criteria applied: PVS1,PM3,PM2_SUP - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Al Jalila Children’s Genomics Center, Al Jalila Childrens Speciality Hospital | Dec 17, 2022 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at